SLCO1B1 and breast cancer: High expression of SLCO1B1 (OATP1B1) and SLCO1B3 (OATP1B3) has also been observed in BC, correlating with increased uptake rates of paclitaxel and potentially influencing the deposition of clinically relevant drugs.